NVCR
NovoCure Ltd.
NASDAQ · Healthcare · Medical - Instruments & Supplies · JE
$16.69
−0.18%Next report
Analyst consensus
- Next report date
- Oct 29, 2026
- EPS estimate
- -$0.21
- Revenue estimate
- $182.4M
Latest reported
- Last report date
- Jul 23, 2026
- EPS actual
- -$0.13
- EPS estimate
- -$0.33
- Revenue actual
- $183.6M
- Revenue estimate
- $172.4M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +26.9%
- Revenue beats (12Q)
- 7
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $36
- PT range
- $20 – $52
- Analysts
- 3
2 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 23, 2026 | -$0.33 | -$0.13 | Beat 60.79% | $183.6M |
| Apr 30, 2026 | -$0.51 | -$0.62 | Miss -21.05% | $174.1M |
| Feb 26, 2026 | -$0.41 | -$0.22 | Beat 46.40% | $174.3M |
| Oct 30, 2025 | -$0.42 | -$0.33 | Beat 21.43% | $167.2M |
| Jul 24, 2025 | -$0.39 | -$0.36 | Beat 7.69% | $158.8M |
| Apr 24, 2025 | -$0.47 | -$0.31 | Beat 34.04% | $155.0M |
| Feb 27, 2025 | -$0.34 | -$0.61 | Miss -79.41% | $161.3M |
| Oct 30, 2024 | -$0.34 | -$0.28 | Beat 17.65% | $155.1M |
| Jul 25, 2024 | -$0.40 | -$0.31 | Beat 22.50% | $150.4M |
| May 2, 2024 | -$0.43 | -$0.36 | Beat 16.28% | $138.5M |
| Feb 22, 2024 | -$0.53 | -$0.45 | Beat 15.09% | $133.8M |
| Oct 26, 2023 | -$0.52 | -$0.46 | Beat 11.54% | $127.3M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 29, 2026